Sunshine Biopharma, Inc. SBFM
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 14/11/2024 |
| Steven Boyd | United States of America | 0 | 0 | 0 | 0 | 0 | 0 % | 14/11/2024 |
| L1 Capital Global Opportunities Master Fund, Ltd. | Cayman Islands | 5285714 | 0 | 5285714 | 0 | 5285714 | 5.3 % | 23/02/2024 |
| EIN | Delaware, United States of America | 3727984 | 0 | 3727984 | 3727984 | 9.99 % | 21/02/2024 | |
| Armistice Capital, LLC | Delaware | 0 | 2130000 | 0 | 2130000 | 0 | 7.6 % | 14/02/2024 |
| Steven Boyd | United States of America | 0 | 2130000 | 0 | 2130000 | 0 | 7.6 % | 14/02/2024 |
| Not Applicable | Canada | 3700000 | 0 | 3700000 | 0 | 3700000 | 16.4 % | 02/11/2022 |
| ROBERT K BEATHARD, 3rd/ ANGELA R BEATHARD | USA | 39231743 | 8.07 % | 29/07/2021 | ||||
| ROBERT K BEATHARD, 3rd/ ANGELA R BEATHARD | USA | 39231743 | 8.07 % | 29/07/2021 |